Achieving more patient-centered trials in cancer immunotherapy: a patient advocate perspective

Immuno-Oncology Insights 2023; 4(2), 61–68

DOI: 10.18609/ioi.2023.010

Published: 18 April 2023
Viewpoint
Deborah Collyar


“We are asking them to contribute their lives to these studies, and to furthering cancer research and treatment. It’s time we work together to make research more relevant for real people.”

Deborah Collyar is the President of Patient Advocates in Research (PAIR), an informal international communication network of ~250 patient advocates who are independent research patient advocates or those who contribute to Patient Advocacy Groups. Here, she explains the existing barriers to clinical trial participation in the immuno-oncology space, and shares her insights on how to modernize eligibility criteria.